欧康医药
(833230)
| 流通市值：7.60亿 | | | 总市值：16.34亿 |
| 流通股本：4670.90万 | | | 总股本：1.00亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 9,036,414.91 | 22,815,394.27 | 18,967,926.25 | 13,734,086.77 |
| 应收票据及应收账款 | 75,141,559.5 | 77,934,713.97 | 79,838,351.47 | 65,615,700.68 |
| 其中：应收票据 | 287,835.45 | 294,680 | - | 83,946 |
| 应收账款 | 74,853,724.05 | 77,640,033.97 | 79,838,351.47 | 65,531,754.68 |
| 应收款项融资 | 2,205,360.9 | 1,717,785.2 | - | - |
| 预付款项 | 14,582,426.44 | 12,269,321.48 | 24,268,872.52 | 23,777,618.8 |
| 其他应收款合计 | 3,980,203.97 | 3,474,936.11 | 2,897,125.92 | 2,846,062.81 |
| 存货 | 101,033,154.46 | 96,062,197.38 | 74,678,189.19 | 76,601,578.69 |
| 其他流动资产 | 3,915,218.63 | 1,914,919.14 | 3,727,076.41 | 5,964,060.21 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 246,779,364.34 | 258,071,338.63 | 234,863,474.45 | 221,065,379.8 |
| 非流动资产: | | | | |
| 固定资产 | 225,636,888.21 | 226,510,644.19 | 201,165,094.89 | 30,778,084.61 |
| 在建工程 | 23,988,186.9 | 25,645,287.67 | 43,880,439.69 | 168,654,074 |
| 使用权资产 | 734,899.26 | 856,666.98 | 160,654.37 | 195,080.51 |
| 无形资产 | 11,283,284.34 | 11,205,919.81 | 11,348,231.25 | 11,491,980.08 |
| 递延所得税资产 | 2,736,241.26 | 2,680,232.02 | 1,478,804.06 | 1,245,853.4 |
| 其他非流动资产 | 8,907,416.12 | 4,241,868.8 | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 273,286,916.09 | 271,140,619.47 | 258,033,224.26 | 212,365,072.6 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 520,066,280.43 | 529,211,958.1 | 492,896,698.71 | 433,430,452.4 |
| 流动负债: | | | | |
| 短期借款 | 20,036,345.34 | 20,015,888.47 | 20,032,336.71 | 20,046,835.33 |
| 应付票据及应付账款 | 53,220,095.52 | 68,962,324.85 | 46,370,419 | 8,132,986.21 |
| 应付账款 | 53,220,095.52 | 68,962,324.85 | 46,370,419 | 8,132,986.21 |
| 合同负债 | 2,920,562.57 | 578,844.76 | 1,268,823.26 | 942,929.33 |
| 应付职工薪酬 | 2,204,560.58 | 4,093,924.59 | 4,009,296.99 | 2,686,778.14 |
| 应交税费 | 570,052.19 | 100,302.42 | 88,180.08 | 75,496.94 |
| 其他应付款合计 | 17,393,535.89 | 14,734,339.4 | 6,115,913.02 | 1,789,972.4 |
| 一年内到期的非流动负债 | 178,391.7 | 237,855.6 | - | - |
| 其他流动负债 | 222,933.94 | 222,347.35 | - | 122,580.81 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 96,746,477.73 | 108,945,827.44 | 77,884,969.06 | 33,797,579.16 |
| 非流动负债: | | | | |
| 租赁负债 | 581,951.76 | 494,610.01 | - | - |
| 递延收益 | 14,067,070.06 | 14,420,464.99 | 5,229,200.38 | 5,307,595.3 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 14,649,021.82 | 14,915,075 | 5,229,200.38 | 5,307,595.3 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 111,395,499.55 | 123,860,902.44 | 83,114,169.44 | 39,105,174.46 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 77,267,304 | 77,267,304 | 77,267,304 | 75,631,404 |
| 资本公积 | 215,557,851.52 | 214,534,047.73 | 213,510,243.94 | 206,036,776.38 |
| 减:库存股 | 8,850,219 | 8,850,219 | - | - |
| 其他综合收益 | -184,972.56 | -51,637.65 | 49,822.77 | 75,970.96 |
| 专项储备 | 4,622,612.77 | 3,756,376.78 | 3,108,121.77 | 2,363,734.94 |
| 盈余公积 | 18,639,990.8 | 18,639,990.8 | 16,194,401.47 | 16,194,401.47 |
| 未分配利润 | 101,186,405.91 | 99,513,799.39 | 99,043,157.35 | 93,364,569.18 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 408,238,973.44 | 404,809,662.05 | 409,173,051.3 | 393,666,856.93 |
| 少数股东权益 | 431,807.44 | 541,393.61 | 609,477.97 | 658,421.01 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 408,670,780.88 | 405,351,055.66 | 409,782,529.27 | 394,325,277.94 |
| 负债和股东权益合计 | 520,066,280.43 | 529,211,958.1 | 492,896,698.71 | 433,430,452.4 |
| 公告日期 | 2025-04-28 | 2025-04-17 | 2024-10-30 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |